However, we used PRISURV as bioinformatics tool uncovering the role of NRN1 in different cancer entities and found a positive correlation of high NRN1 expression levels with cancer survival outcome of breast cancer, lung cancer, and cervical cancer patients supporting our data. The gene discussed is NRN1; the disease is lung cancer.